PAF increases vascular permeability without increasing pulmonary arterial pressure in the rat

In vivo pulmonary arterialcatheterization was used to determine the mechanism by whichplatelet-activating factor (PAF) produces pulmonary edema inrats. PAF induces pulmonary edema by increasing pulmonarymicrovascular permeability (PMP) without changing the pulmonarypressure gradient. Rats were cannulated for measurement of pulmonaryarterial pressure (Ppa) and mean arterial pressure. PMP wasdetermined by using either in vivo fluorescent videomicroscopy or theex vivo Evans blue dye technique. WEB 2086 was administeredintravenously (IV) to antagonize specific PAF effects. Threeexperiments were performed: 1) IV PAF, 2) topical PAF, and 3) Escherichia coli bacteremia. IV PAFinduced systemic hypotension with a decrease in Ppa. PMP increasedafter IV PAF in a dose-related manner. Topical PAF increased PMP butdecreased Ppa only at high doses. Both PMP (88 ± 5%) and Ppa(50 ± 3%) increased during E. coli bacteremia.PAF-receptor blockade prevents changes in Ppa and PMP after bothtopical PAF and E. coli bacteremia. PAF, which has beenshown to mediate pulmonary edema in prior studies, appears to act inthe lung by primarily increasing microvascular permeability. Thepresence of PAF might be prerequisite for pulmonary vascularconstriction during gram-negative bacteremia.